201 related articles for article (PubMed ID: 2921504)
1. The role of sinusoidal stenoses in portal hypertension of liver cirrhosis.
Shibayama Y; Nakata K
J Hepatol; 1989 Jan; 8(1):60-6. PubMed ID: 2921504
[TBL] [Abstract][Full Text] [Related]
2. On the pathogenesis of portal hypertension in cirrhosis of the liver.
Shibayama Y
Liver; 1988 Apr; 8(2):95-9. PubMed ID: 3367713
[TBL] [Abstract][Full Text] [Related]
3. Relation of sinusoidal stenoses following hepatocyte swelling to hepatic vascular resistance in experimental liver cirrhosis.
Shibayama Y; Nakata K
Liver; 1989 Feb; 9(1):36-42. PubMed ID: 2921939
[TBL] [Abstract][Full Text] [Related]
4. Localization of increased hepatic vascular resistance in liver cirrhosis.
Shibayama Y; Nakata K
Hepatology; 1985; 5(4):643-8. PubMed ID: 4018737
[TBL] [Abstract][Full Text] [Related]
5. Sinusoidal stenosis as the cause of portal hypertension in choline deficient diet induced fatty cirrhosis of the rat liver.
Wada K; Fujimoto K; Fujikawa Y; Shibayama Y; Mitsui H; Nakata K
Acta Pathol Jpn; 1974 Mar; 24(2):207-17. PubMed ID: 4407748
[No Abstract] [Full Text] [Related]
6. Role of septal fibrosis in development of hepatic circulatory disturbance in the presence of liver cell enlargement.
Shibayama Y; Nakata K
Liver; 1992 Apr; 12(2):84-9. PubMed ID: 1619984
[TBL] [Abstract][Full Text] [Related]
7. Anatomical lesions being responsible for development of portal hypertension in carbon tetrachloride-induced rat liver cirrhosis.
Fujimoto K; Nakata K
Acta Pathol Jpn; 1972 Nov; 22(4):625-35. PubMed ID: 4679153
[No Abstract] [Full Text] [Related]
8. Experimental reduction of portal hypertension by mechanical increase of liver portal flow.
Habib N; Houssin D; Carol C; Cardoso J; Boisseau C; Calmus Y; Ozier Y; Quere J; Wood C; McIntyre N
Lancet; 1991 Jan; 337(8732):16-7. PubMed ID: 1670651
[TBL] [Abstract][Full Text] [Related]
9. The relation of periportal fibrosis to portal hypertension.
Shibayama Y; Nakata K
J Hepatol; 1990 Nov; 11(3):313-7. PubMed ID: 2290021
[TBL] [Abstract][Full Text] [Related]
10. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
12. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
13. Acute portal vein stenosis. An experimental study on portal circulation and hepatosplenic function.
Rozga J; Jeppsson B; Hägerstrand I; Bengmark S
Acta Chir Scand; 1985; 151(2):125-31. PubMed ID: 4002975
[TBL] [Abstract][Full Text] [Related]
14. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
Van de Casteele M; Hösli M; Sägesser H; Reichen J
J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
17. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.
Takashimizu S; Kojima S; Nishizaki Y; Kagawa T; Shiraishi K; Mine T; Watanabe N
Tokai J Exp Clin Med; 2011 Jul; 36(2):37-43. PubMed ID: 21769771
[TBL] [Abstract][Full Text] [Related]
18. The role of pericentral fibrosis in experimental portal hypertension in rats.
Shibayama Y; Nakata K
Liver; 1991 Apr; 11(2):94-9. PubMed ID: 2051907
[TBL] [Abstract][Full Text] [Related]
19. Partial portal vein ligation plus thioacetamide: a method to obtain a new model of cirrhosis and chronic portal hypertension in the rat.
Méndez-López M; Méndez M; Sánchez-Patán F; Casado I; Aller MA; López L; Corcuera MT; Alonso MJ; Nava MP; Arias J; Arias JL
J Gastrointest Surg; 2007 Feb; 11(2):187-94. PubMed ID: 17390171
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
Fortea JI; Zipprich A; Fernandez-Mena C; Puerto M; Bosoi CR; Almagro J; Hollenbach M; Bañares J; Rodríguez-Sánchez B; Cercenado E; Clément MA; Rose CF; Bañares R; Vaquero J; Ripoll C
Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
